Overview of 2025 Results#
Advanced Medical Solutions Group has released its fiscal year 2025 results, which align closely with its earlier trading statement from January. The company has demonstrated significant growth in both its Surgical and Woundcare divisions.
Financial Performance#
The company reported revenues of £228.9 million and an adjusted EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of £49.9 million, resulting in a margin of 21.8%. These figures are consistent with both the January trading statement and the expectations set by analysts.
Division Highlights#
The Surgical Care division was the standout performer, achieving a remarkable 36% growth when adjusted for constant currency. Within this segment, the ex-Peters area grew by approximately 11%, benefiting from strong performance across most product categories. Meanwhile, the Wound Care division saw a revenue increase of 9% in constant currency, driven by robust demand for customer-branded products and bulk materials.
Future Outlook#
Looking ahead to fiscal year 2026, Advanced Medical Solutions is optimistic about maintaining revenue and EBITDA levels in line with current market expectations. Analysts forecast revenues of £244.6 million and an adjusted profit before tax of £40.6 million. The company anticipates continued strong growth in Surgical Care and modest growth in Woundcare as long-term supply agreements come into effect. Furthermore, it expects to generate strong cash flow while carefully managing capital to reduce debt and invest in innovation and manufacturing improvements.
The company does not foresee any significant impact from the ongoing conflict in the Middle East.